导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.64% | 973/1050 |
| 近一周 | -1.19% | 160/1104 |
| 近一月 | -2.33% | 245/1102 |
| 近一季 | -2.00% | 325/1092 |
| 近半年 | -13.19% | 851/1070 |
| 近一年 | -25.05% | 960/1018 |
| 近两年 | 2.42% | 877/926 |
| 近三年 | -19.26% | 769/834 |
| 成立以来 | 9.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.93% 1000/1070 |
-12.36% 970/1101 |
- - |
- - |
| 2025 | 9.35% 834/1065 |
6.57% 311/1014 |
1.11% 603/1038 |
10.70% 841/1050 |
-8.32% 838/1065 |
| 2024 | 3.27% 492/1011 |
-6.64% 644/960 |
3.43% 145/983 |
15.92% 182/991 |
-7.74% 810/1011 |
| 2023 | -24.58% 769/952 |
2.93% 451/880 |
-12.18% 810/895 |
-7.75% 484/915 |
-9.56% 839/952 |
| 2022 | -20.03% 323/867 |
-18.80% 458/773 |
16.68% 79/806 |
-18.68% 729/845 |
3.79% 251/867 |
| 2021 | -17.09% 525/740 |
-4.72% 329/580 |
12.11% 309/659 |
-17.15% 638/704 |
-6.32% 620/740 |
| 2020 | 74.67% 116/554 |
-0.55% 174/419 |
26.31% 178/466 |
15.87% 132/517 |
20.00% 119/554 |
| 2019 | - - |
- - |
- - |
5.51% 193/390 |
6.25% 302/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 广发消费升级股票 VS. 东吴新产业精选股票A(580008) |